Hatake (@rhatake_jp) profile picture

医療, 生成 AI, デザイン, PdM, #COYS の話を雑多にします | 秋田出身 | 東大経済→リクルート→Goodpatch→Ubie

トーキョー
Joined March 2011
Photo by Hatake (@rhatake_jp)Photo by Hatake (@rhatake_jp)Photo by Hatake (@rhatake_jp)Photo by Hatake (@rhatake_jp)Photo by Hatake (@rhatake_jp)Photo by Hatake (@rhatake_jp)Photo by Hatake (@rhatake_jp)Photo by Hatake (@rhatake_jp)Photo by Hatake (@rhatake_jp)Photo by Hatake (@rhatake_jp)
今場所誰が優勝するんだろう、実力拮抗してるな〜
287
陶芸たのしいね。一つとして同じものがない
2
345
今場所は大の里・霧島・熱海富士の三つ巴かな。藤ノ川と藤凌駕に勢いがある…! #sumo
1
1
591
年末がおれを調整する。した
193
デキとマディソンとバーネットくんだそう #COYS
272
うっひょーーー
#コジプロ展 小島監督による大量の修正指示(jiraチケット)が一番興奮した
439
え!北海道もう雪ふってるの
227
Hatake retweeted
日本人の個人情報流出しすぎて値段が付かなくなってるって見かけて椅子から転げ落ちた
179
11,923
1,013
137,423
6,149,135
いつの間にかマンチェスターユナイテッド17位まで落ちててスパーズと入れ替わったのか…w
2
1,034
うおおスパーズ三連勝!久しぶりすぎる。最後バーネットくんとデキの惜しいシーンも見られて希望 #COYS
4
835
ヘッケ決めた!!! #COYS
215
スパーズがずっと左右振ってるから鎌田ウォートン後半もたないのでは #COYS
946
グレイ!!!マディソンに駆け寄るのいいね #COYS
227
自信持っテル #COYS
226
マテタ red で数的優位はだいぶやりやすくなるな #COYS
565
展開が面白すぎる。「Anthropicが社員1名のバイオテックスタートアップを買収しました。その1人は私です。ずっと匿名アカウントでやってきましたが、ついに名を明かします…」と。Claudeをフル活用して1人で筋ジストロフィーのパイプラインを開発、、!?いよいよ1人製薬企業の時代か!?
Surprise 1: Anthropic acquired a one-person biotech . . . Surprise 2: that person is me Surprise 3: I’m here to tell you all about it Yes, this is what you think it is; after 6 yrs of increasingly loose anonymity: the Professor Oak reveal post …and yes, it has gotten so boring around here that I’m literally doxxing myself to spice up the timeline ------- Ok, allow me to introduce myself. My name is Cody Tranbarger. I mostly tweet, but occasionally find time to dabble in drug dev & starting/building biotechs. My past lives span the VC, crossover, startup continuum; Prof Oak has been my way of keeping a digital foot in those worlds, despite having my physical feet planted elsewhere. The past 18 mo, ‘elsewhere’ was Mithril Medicine, a co. I founded to develop bsAbs for LAMA2-CMD & other ECM-related genetic diseases. Mithril was born out of hands-on building with @MikeNGladstone, @JasonPaulRhodes, @LifeSciVC, & team @atlasventure. Somehow, I made enough half-decent calls along the way (even a broken clock is right twice a day, eh?) to convince them Mithril/I warranted a small seed. While I can hardly rationalize such an outrageously cavalier bet, I’m grateful for it, & I'd partner with Atlas again in a heartbeat. In typical AV fashion, Mithril’s primordial form was virtual, decentralized, & ultra-lean. This stage tends to be short-lived, but for Mithril, it worked surprisingly well, for surprisingly long, thanks in part to the rapid maturation of the AI tools I used liberally. Eventually, Mithril became a bit of an experiment itself - to find the upper bound of how far it could scale as a single operator + a bunch of Claude (+ a stellar bench of part-time consultants). In parallel, I started spending time with @nc_frey, @an1lam, & @CoefficientBio team; and promptly experienced, for the 1st time, AI at the frontier. Soon thereafter, Mithril stopped looking like an experiment, & started looking like a preview of an entirely new operating model. From that spark came “Pipeline-in-a-Person.” The idea immediately resonated when we shared it here back in April; and it was central to the shared vision that led to Anthropic’s acquisition of Mithril, & my joining the team. Why join Anthropic? Three reasons. (1) For Mithril, the programs continue, with more resources & infrastructure behind them, and as much Claude as I can put to work. (2) For me, the chance to start several more programs, & find out how many one person can actually run in parallel - an almost unprecedented luxury for a curious drug hunter. (3) For our mission, a path to institutionalize & scale this new way of working, then put it in the hands of all of biopharma, all over the world - which, candidly, I find the most energizing. Will AI x Bio cure diseases? Unequivocally yes, imo… but not by the route that gets the most airtime. Rather than timeline acceleration & compression, I see orchestration & parallelization as today's low-hanging fruit. Most drug hunters see a handful of go/no-go calls in a career, & spend entirely too much of the rest trading emails (my inbox can attest). Give them the bandwidth to run several programs at once, and the time to focus on scientific judgment, and I’m willing to bet they’ll make better calls. And at scale, better calls translate to more drugs, higher hit rates, broader patient impact, & likely, a disease or 10 or 100 cured. I couldn't be more excited to build toward that future @AnthropicAI. Finally, a heartfelt thank you to BioTwitter/X. The end of anonymity is bittersweet, but if anyone’s earned a proper introduction, you all have. It’s difficult to overstate how much this app has done for me: a decade of education, plenty of friends, many job opportunities, several mentors, a few investors, even a co-founder (fmr). It was the generosity of this community that inspired me to start posting 6 years ago, after just as many years lurking. I hope I’ve been able to pay it forward, in my own small way. But, to be clear, Prof Oak isn’t going anywhere. Same beat, same themes, and now, a front-row seat to drug development at the frontier. Stay tuned for dispatches from the trenches; and remember... Gotta Cure 'Em All
4
62
6
372
36,299
今夜は牛タンよ
2
239
【予約開始】 『ナショナル ジオグラフィック プロの撮り方 ポール・ニックレンの写真講座 動物写真を極める』 ナショジオの誌面やMacの壁紙で目にした、あのホッキョクグマやペンギンの写真。20年間ナショジオを代表する写真家として活躍してきたポール・ニックレンが、撮影テクニックと哲学のすべてを伝える。 動物写真家・岩合光昭推薦! 刊行:2026年12月2日 詳細はこちら:natgeo.nikkeibp.co.jp/atcl/p…
19
1
83
12,555